Inner Mongolia Kingdomway Pharmaceutical Co., Ltd.

China

Back to Profile

1-10 of 10 for Inner Mongolia Kingdomway Pharmaceutical Co., Ltd. Sort by
Query
Aggregations
Jurisdiction
        United States 6
        World 4
Date
2024 November 1
2024 4
2023 2
2020 4
IPC Class
C12N 1/20 - BacteriaCulture media therefor 3
C12P 7/26 - Ketones 3
C07C 46/10 - SeparationPurificationStabilisationUse of additives 2
C12N 9/02 - Oxidoreductases (1.), e.g. luciferase 2
C12P 7/66 - Preparation of oxygen-containing organic compounds containing the quinoid structure 2
See more
Status
Pending 3
Registered / In Force 7
Found results for  patents

1.

10

      
Application Number CN2023096228
Publication Number 2024/239309
Status In Force
Filing Date 2023-05-25
Publication Date 2024-11-28
Owner
  • KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (China)
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • JIANGSU CHENGXIN PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Zhu, Jun
  • Wang, Bingrong
  • Xu, Fei
  • Xing, Fei
  • Li, Dan

Abstract

1010101010.

IPC Classes  ?

  • C12P 23/00 - Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase
  • C12N 15/70 - Vectors or expression systems specially adapted for E. coli

2.

GLYCERIC ACID, GLYCERATE, AND COMPOSITION THEREOF

      
Application Number 18594000
Status Pending
Filing Date 2024-03-04
First Publication Date 2024-08-15
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
  • KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (China)
Inventor
  • Zhen, Ming
  • Liu, Mengjing
  • Wang, Li
  • Liu, Qiyue
  • Chen, Biqin
  • Wang, Bingrong
  • Li, Dan
  • Wu, Yi
  • Zhan, Guanghuang

Abstract

The present disclosure provides a crystalline form of calcium D-glycerate of formula The present disclosure provides a crystalline form of calcium D-glycerate of formula The present disclosure provides a crystalline form of calcium D-glycerate of formula and a method for preparing the crystalline form of calcium D-glycerate of formula (I). The crystalline form may be characterized by having X-ray powder diffraction pattern (XRPD) diffraction peaks (2θ degrees) at 12.9°±0.2°, 20.9°±0.2°, and 31.7°±0.2°.

IPC Classes  ?

3.

GLYCERIC ACID, GLYCERATE, AND COMPOSITION THEREOF

      
Application Number CN2023106405
Publication Number 2024/164494
Status In Force
Filing Date 2023-07-07
Publication Date 2024-08-15
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
  • KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (China)
Inventor
  • Zhen, Ming
  • Liu, Mengjing
  • Wang, Li
  • Liu, Qiyue
  • Chen, Biqin
  • Wang, Bingrong
  • Li, Dan
  • Wu, Yi
  • Zhan, Guanghuang

Abstract

The present disclosure provides a crystalline form of calcium D-glycerate of formula (I) and a method for preparing the crystalline form of calcium D-glycerate of formula (I). The crystalline form may be characterized by having X-ray powder diffraction pattern (XRPD) diffraction peaks (2θ degrees) at 12.9±0.2, 20.9±0.2, and 31.7±0.2.

IPC Classes  ?

  • C07C 59/10 - Polyhydroxy carboxylic acids
  • C07C 51/41 - Preparation of salts of carboxylic acids by conversion of the acids or their salts into salts with the same carboxylic acid part
  • A61K 31/191 - Acyclic acids having two or more hydroxy groups, e.g. gluconic acid

4.

10

      
Application Number 18343727
Grant Number 12221645
Status In Force
Filing Date 2023-06-28
First Publication Date 2024-01-04
Grant Date 2025-02-11
Owner
  • KINGDOMWAY BIOTECHNOLOGY (JIANGSU) CO., LTD. (China)
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
Inventor
  • Zhu, Jun
  • Wang, Bingrong
  • Xu, Fei
  • Xing, Fei
  • Li, Dan

Abstract

10.

IPC Classes  ?

  • C12P 7/66 - Preparation of oxygen-containing organic compounds containing the quinoid structure
  • C12N 9/02 - Oxidoreductases (1.), e.g. luciferase

5.

METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS

      
Application Number 18171647
Status Pending
Filing Date 2023-02-20
First Publication Date 2023-06-29
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Zhan, Guanghuang
  • Wu, Yi
  • Chen, Biqin
  • Zhu, Zhichun
  • Li, Dan

Abstract

Controlled coenzyme Q10 (CoQ10) fermentation production processes and methods for controlling the CoQ10 fermentation production processes are provided in the present disclosure. The processes may include growing a microbial culture of bacteria by providing a carbon source and an oxygen source for a predetermined period of time, thereby producing CoQ10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.

IPC Classes  ?

6.

METHODS FOR A CONTROLLED COENZYME Q10 FERMENTATION PRODUCTION PROCESS

      
Application Number 18171650
Status Pending
Filing Date 2023-02-20
First Publication Date 2023-06-29
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Zhan, Guanghuang
  • Wu, Yi
  • Chen, Biqin
  • Zhu, Zhichun
  • Li, Dan

Abstract

Controlled coenzyme Q10 (CoQ10) fermentation production processes and methods for controlling the CoQ10 fermentation production processes are provided in the present disclosure. The processes may include growing a microbial culture of bacteria by providing a carbon source and an oxygen source for a predetermined period of time, thereby producing CoQ10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.

IPC Classes  ?

7.

Methods for a controlled coenzyme Q10 fermentation production process

      
Application Number 16599184
Grant Number 11584942
Status In Force
Filing Date 2019-10-11
First Publication Date 2020-11-12
Grant Date 2023-02-21
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Zhan, Guanghuang
  • Wu, Yi
  • Chen, Biqin
  • Zhu, Zhichun
  • Li, Dan

Abstract

10-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.

IPC Classes  ?

8.

10 FERMENTATION PRODUCTION PROCESS

      
Application Number CN2019085990
Publication Number 2020/223923
Status In Force
Filing Date 2019-05-08
Publication Date 2020-11-12
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Zhan, Guanghuang
  • Wu, Yi
  • Chen, Biqin
  • Zhu, Zhichun
  • Li, Dan

Abstract

1010101010-containing bacteria, carbon dioxide, and lactate in the bacterial culture. During various stages of the production process, the concentration of carbon dioxide may be maintained at predetermined levels, respectively. Alternatively or additionally, during various stages of the production process, the concentration of lactate may be maintained at predetermined levels, respectively.

IPC Classes  ?

  • C12P 7/66 - Preparation of oxygen-containing organic compounds containing the quinoid structure
  • C12R 1/01 - Bacteria or actinomycetales

9.

Systems and methods for producing coenzyme Q10

      
Application Number 16690305
Grant Number 11773043
Status In Force
Filing Date 2019-11-21
First Publication Date 2020-03-19
Grant Date 2023-10-03
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Liao, Weicheng
  • Wang, Bingrong
  • Li, Dan
  • Xu, Luming
  • Jiang, Sifu

Abstract

10-containing intermediate product.

IPC Classes  ?

10.

10

      
Application Number CN2018098991
Publication Number 2020/029017
Status In Force
Filing Date 2018-08-06
Publication Date 2020-02-13
Owner
  • INNER MONGOLIA KINGDOMWAY PHARMACEUTICAL CO., LTD. (China)
  • XIAMEN KINGDOMWAY GROUP COMPANY (China)
Inventor
  • Liao, Weicheng
  • Wang, Bingrong
  • Li, Dan
  • Xu, Luming
  • Jiang, Sifu

Abstract

10101010101010101010-containing intermediate product.

IPC Classes  ?

  • C07C 46/10 - SeparationPurificationStabilisationUse of additives